COVID-19: Click here for what to expect at ChristianaCare during COVID-19

Cancer Research


At ChristianaCare’s Helen F. Graham Cancer Center & Research Institute

Dr. Bruce Boman conducts cancer research at ChristianaCare Dr. Pradhan-Bhatt leads cancer research at ChristianaCare Dr. Eric Kmiec conducts gene editing cancer research at ChristianaCare Dr. Mourtada conducts radiation oncology cancer research at ChristianaCare Dr. Sims-Mourtada irradiates a cancer research specimen at ChristianaCare

At ChristianaCare’s Helen F. Graham Cancer Center & Research Institute, ground-breaking cancer research is every-day reality. The Graham Cancer Center brings scientists and clinicians together to investigate innovative ways to diagnose cancer earlier and treat it more effectively.

Because of its membership in the prestigious National Cancer Institute NCI Community Oncology Research Program (NCORP), the Graham Cancer Center offers leading-edge NCORP clinical trials to the patients we are privileged to serve. The Graham Cancer Center also offers a robust pharmaceutical clinical trials program.

In addition to clinical trials, the Graham Cancer Center has a translational cancer research program, the Cawley Center for Translational Cancer Research (CTCR) that brings scientific discoveries from the bench to the bedside of patients, investigating breast cancer, colon cancer, radiation oncology and tissue engineering. The Graham Cancer Center conducts industry-leading genetic engineering cancer research at the Gene Editing Institute.

The Graham Cancer Center collaborates with other institutions in cancer research, having close partnerships with The Wistar Institute, the University of Delaware, Nemours / A.I. du Pont Hospital for Children, Rice University / BioScience Research Collaborative and the Delaware Biotechnology Institute, among others.